Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma

Keyphrases

• Epidemiologic 100%
• Endometrioid Carcinoma 100%
• Serous Cell 100%
• Papillary Serous 100%
• Endometrial Clear Cell Carcinoma 100%
• Clear Cell 61%
• Endometrioid 55%
• Metastasis 27%
• Histology 22%
• Clear Cell Tumor 22%
• Depth of Myometrial Invasion 16%
• Extrauterine 16%
• Tumor 11%
• Surgical Staging 11%
• Serous Tumor 11%
• Preoperative Diagnosis 11%
• Cell-based 5%
• Cancer Patients 5%
• Endometrial Cancer 5%
• Stage III-IV 5%
• Endometrium 5%
• Poor Survival 5%
• University Medical Centre 5%
• Endometrial Adenocarcinoma 5%
• Fisher's Exact Test 5%
• Sampling Rate 5%
• Tumor Grade 5%
• Histological Subtypes 5%
• Myometrium 5%
• Duke University 5%
• Clinical Stage I 5%
• Lymph Node Dissection 5%
• Hysterectomy 5%
• Tumor Histology 5%
• Wilcoxon Rank Sum Test 5%
• Intraoperative Assessment 5%
• Difference in Medians 5%
• In(III) 5%
• Testing Trends 5%
• Ordered Category 5%
• Misassignment 5%

Medicine and Dentistry

• Cancer 100%
• Clear Cell 100%
• Endometrioid Carcinoma 100%
• Metastatic Carcinoma 38%
• Tumor 38%
• Clear Cell Carcinoma 30%
• Endometrium 15%
• Neoplasm 7%
• Clinical Stage 7%
• Myometrium 7%
• Fisher Exact Test 7%
• Retroperitoneal Lymph Node Dissection 7%
• Hysterectomy 7%
• Rank Sum Test 7%
• Uterine Cancer 7%